These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 8885958)

  • 61. Dose Adjustment of Stimulants for Children with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended Doses.
    Ross L; Sapre V; Stanislaus C; Poulton AS
    CNS Drugs; 2020 Jun; 34(6):643-649. PubMed ID: 32300972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment.
    Durá-Travé T; Yoldi-Petri ME; Gallinas-Victoriano F; Zardoya-Santos P
    J Child Neurol; 2012 May; 27(5):604-9. PubMed ID: 22190507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder.
    Becker SP; Froehlich TE; Epstein JN
    J Dev Behav Pediatr; 2016 Jun; 37(5):395-404. PubMed ID: 27011002
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder.
    Chelonis JJ; Johnson TA; Ferguson SA; Berry KJ; Kubacak B; Edwards MC; Paule MG
    Exp Clin Psychopharmacol; 2011 Apr; 19(2):145-53. PubMed ID: 21463072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder.
    Levy LD; Fleming JP; Klar D
    Int J Obes (Lond); 2009 Mar; 33(3):326-34. PubMed ID: 19223848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis.
    Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu EQ; Erder MH
    J Med Econ; 2013 Jul; 16(7):962-75. PubMed ID: 23621503
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An 8-year follow-up of treated obese children: children's, process and parental predictors of successful outcome.
    Moens E; Braet C; Van Winckel M
    Behav Res Ther; 2010 Jul; 48(7):626-33. PubMed ID: 20398894
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heart rate variability and methylphenidate in children with ADHD.
    Buchhorn R; Conzelmann A; Willaschek C; Störk D; Taurines R; Renner TJ
    Atten Defic Hyperact Disord; 2012 Jun; 4(2):85-91. PubMed ID: 22328340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study.
    Newcorn JH; Stein MA; Cooper KM
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):187-96. PubMed ID: 20578931
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.
    Nemoda Z; Angyal N; Tarnok Z; Gadoros J; Sasvari-Szekely M
    Neuropharmacology; 2009 Dec; 57(7-8):731-3. PubMed ID: 19733552
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
    Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
    Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
    Lipkin PH; Butz AM; Cozen MA
    J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ten years of experience with 1,000 hyperactive children in a private practice.
    Eichlseder W
    Pediatrics; 1985 Aug; 76(2):176-84. PubMed ID: 4022690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictive factors for more than 3 years' duration of central stimulant treatment in adult attention-deficit/hyperactivity disorder: a retrospective, naturalistic study.
    Torgersen T; Gjervan B; Nordahl HM; Rasmussen K
    J Clin Psychopharmacol; 2012 Oct; 32(5):645-52. PubMed ID: 22926598
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sustained release methylphenidate: pharmacokinetic studies in ADDH males.
    Birmaher B; Greenhill LL; Cooper TB; Fried J; Maminski B
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):768-72. PubMed ID: 2793805
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder.
    Donnelly M; Haby MM; Carter R; Andrews G; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):592-601. PubMed ID: 15298581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of a skipped dose (placebo) of methylphenidate on the learning and retention of a motor skill in adolescents with Attention Deficit Hyperactivity Disorder.
    Fox O; Adi-Japha E; Karni A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):391-6. PubMed ID: 24332892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.